LIUDMILA EVDOKIMOVA: Open Payments
NPI 1053943282 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 27 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $374 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $174 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 2 | $38 |
| Lundbeck LLC | 1 | $18 |
| JAZZ PHARMACEUTICALS INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, UBRELVY, QULIPTA, Ozempic, Wegovy, MOUNJARO, VYEPTI, XYWAV.
Industry payments across NJ — which companies pay providers there.
